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Poxviral DNA topoisomerases are sequence-specific enzymes whose activities are thought to influence such diverse
processes as transcription, DNA replication, and genetic recombination. To obtain further insights into the relatedness
of these enzymes, and their influence on virus-mediated recombination, we have determined the target-specificity and
other catalytic properties of the Shope fibroma virus (SFV) topoisomerase. SFV topoisomerase was expressed in Esche-
richia coli and purified as a glutathione S-transferase (GST) or (his)6-tagged fusion protein. The recombinant Leporipox-
virus (SFV) enzyme displayed catalytic properties very similar to vaccinia topoisomerase. In particular SFV topoisomerase
recognizes the same pentanucleotide motif [5*-(C/T)CCTT-3*] and promotes the same DNA relaxation, strand transfer,
and strand cleavage reactions catalyzed by the Orthopoxviral (vaccinia) enzyme. The SFV enzyme can also efficiently
cleave DNA 3* of the variant site 5*-CCCTG-3* in certain sequence contexts. These studies identified several sites where
SFV topoisomerases interact with a recombinational substrate and permitted a comparison of recombination frequencies
across intervals which did, or did not, span these sites. We failed to detect any effect of topoisomerase-recognition
sites on recombination frequencies, except for a small (2-fold) stimulation seen when the substrates encoded a nearby
poxviral promoter. This and other work shows that poxviral topoisomerases from several genera share common target
specificities, but other enzymatic systems probably catalyze the high-frequency recombination seen in poxvirus-infected
cells. q 1996 Academic Press, Inc.
Poxviruses encode type I DNA topoisomerases which topoisomerase (4) fused to the GST carboxyl terminus in
vector pGEX-2T (pCF101, data not shown), while a sec-catalyze the Mg/2-independent relaxation of both posi-
tively and negatively supercoiled DNAs (1–4). An un- ond encoded a PCR-amplified open-reading frame
cloned into the ‘‘his-tag’’ vector pET21a (pCF111; Fig. 1A).usual feature of the reaction is the high degree of sub-
strate specificity displayed by these enzymes. In vitro Induction of protein synthesis led to the synthesis of 64-
and 40-kDa proteins in pCF101- and pCF111-transformedanalyses have shown that orthopoxvirus (vaccinia) and
parapoxvirus (orf) topoisomerases act primarily through E. coli cells, respectively, which were purified using ei-
ther glutathione agarose (pCF101) or Ni-chelate affinitya break located on the 3* side of the sequence 5*-
(C/T)CCTT-3* (5, 6) at which site the vaccinia enzyme chromatography and HPLC (pCF111) (9). The three forms
of recombinant protein that could thus be isolated [GSTcan also catalyze DNA strand transfer (7) and illegitimate/
site-specific recombination (8). Since a similar character- fusion, thrombin-cleaved GST fusion, or (his)6-tagged]
displayed identical catalytic properties and lacked anyization of the topoisomerase encoded by leporipoxvi-
ruses has not been reported, we have examined the detectable nonspecific endonuclease. The histidine-
tagged protein was found to be the form most easilysubstrate specificity of the Shope fibroma virus (SFV)
topoisomerase first cloned by Upton and colleagues (4). purified in high yield (Fig. 1B) and expressed a specific
activity comparable to that reported for native vacciniaBy using a substrate amenable to high-resolution genetic
mapping, this analysis also permitted a test of the hypoth- topoisomerase (Fig. 1C) (2). The SFV enzyme also
showed the same complex pattern of stimulation andesis that poxviral topoisomerases might also promote
general recombination (8). inhibition by Mg/2 (2) and ATP (10, 11) as the vaccinia
enzyme (data not shown).To establish the sequence specificity of SFV topoisom-
erase we first prepared recombinant fusion proteins and Cleavage site specificity was established using sev-
eral different approaches. In the first study pUC18 DNAthen examined how they would interact with DNA. One
such expression construct encoded the 37.0-kDa SFV was restricted and end-labeled and then incubated with
the GST–topoisomerase fusion protein. As a control
these DNAs were also incubated with GST protein puri-1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (519) 837-2075. E-mail: dhevans@uoguelph.ca. fied in an identical manner from vector-transformed cells.
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FIG. 2. Reactions catalyzed by SFV topoisomerase. (A) DNA cleav-
age. XbaI linearized pUC18 DNA (10 ng) was 3* end-labeled using
Klenow DNA polymerase and [a-32P]dCTP and then used directly (lanes
2–5) or digested with HindIII (lanes 6–9) or EcoRI (lanes 10–13) prior
to incubation with SFV topoisomerase (0.3–3.0 pmol) or a GST control
extract (‘‘0 pmol’’). The products generated by SDS treatment were then
fractionated on a 1.6% alkaline agarose gel and detected by autoradiog-
raphy. The positions of the 32P-labeled ends are shown schematically.
(B) DNA strand transfer. About 0.6 pmol of the 3*-end labeled acceptor
molecule, d(ATTCCGATAGTG-32P-A), was incubated with 0–3.0 pmol
of d(TCGCCCTTATTC)rd(GAATAAGGGCGA) plus 15 pmol of (his)6-
tagged topoisomerase. These reactions were incubated at 377 for 5
min and stopped by adding formamide to 50% (v/v) final concentration.FIG. 1. Topoisomerase expression, purification, and assay. (A) (His)6-
The reaction products were heated to 807 for 3 min, size-fractionatedtagged expression construct. The primers d(GGGTGGATCCATGAG-
on a 16% denaturing polyacrylamide gel, and labeled molecules wereAGCTTTTACA) and d(GGGTAAGCTTCACCGTTTGTGTGTT) were used
detected by autoradiography.in a PCR reaction to generate a DNA encoding the topoisomerase
open-reading frame. The product was digested with BamHI and HindIII
and then directionally cloned into vector pET21a to produce pCF111. The reactions were stopped by adding 1% sodium dode-
The recombinant protein encodes 14 and 13 amino acid N- and C-
cyl sulfate (SDS) to denature and fix the covalent interme-terminal extensions, respectively (lower case). (B) Purification of (his)6-
diates formed by DNA-bound topoisomerases, and thetagged topoisomerase illustrated by gel electrophoretic analysis. Cells
were transformed with either pET21a [vector control (C)] or pCF111 (T), products were fractionated on alkaline agarose gels (Fig.
IPTG-treated to induce protein synthesis, and soluble extracts isolated 2A). No effects were seen using control protein (lanes 2,
(Fractions I, lanes 2 and 3). Each Fraction I was applied to a Ni/2 6, and 10) while the recombinant topoisomerase gener-
chelate affinity column (HisrBind, Novagen) and bound proteins were
ated cleavage products nearly identical to those whicheluted with imidazole (Fractions II, lanes 4 and 5). Topoisomerase-
vaccinia topoisomerase catalyzes on a pUC19 templatecontaining Fraction II was dialyzed, applied to a DEAE-HPLC column,
(5). Therefore, SFV topoisomerase must also recognizeand eluted with a NaCl gradient. Active fractions were pooled to pro-
duce Fraction III (lane 6). Equal volumes of topoisomerase and control and cleave DNA at the sequence 5*-(C/T)CCTT-3* (5).
extracts were loaded on the gel to illustrate the relative purity of Frac-
tions I and II. (C) Relaxation of superhelical DNA by SFV topoisomerase.
The HPLC-purified protein shown in (B) (Fraction III, 0–2 pmol) was roquinephosphate (18). Half relaxation required 10 ng (0.25 pmol) of
incubated for 30 min with 1 mg of supercoiled-pBR322 DNA. Topoiso- protein under these conditions which indicates a specific activity (2)
mers were then separated on a 1.5% agarose gel containing chlo- of 120,000 U/mg.
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FIG. 3. Topoisomerase cleavage sites within the cI gene of phage lambda. (A) Cleavage of DNA encoding the cI gene. The lambda cI gene was
excised from plasmid pRPts307S (17) as a 1-kb SpeI–XhoI fragment, 3* end-labeled at the SpeI site, and 50 ng treated with 0–2.2 pmol of SFV
topoisomerase. The products generated by SDS treatment were then fractionated on a 1.6% alkaline agarose gel and detected by autoradiography.
A 430 base fragment was generated by cleavage at the cI variant site and a 700 base fragment arose from cleavage at a consensus site. (B)
Cleavage at the cI variant site. An oligonucleotide duplex encoding the cI variant site was synthesized bearing a recessed 3*-end on the scissile
strand and then filled in using Klenow polymerase and [a-32P]dCTP. Approximately 15 pmol of the labeled product [d(TTGACCCTGAGCAGGCTGT-
32P-C)rd(GACAGCCTGCTCAGGGTCAA)] was treated with 0–4 pmol of (his)6-tagged topoisomerase in reactions containing 50 mM TrisrHCl, pH
7.5, and the products were separated on a 10% denaturing acrylamide gel. Comigration of the cleavage products (lanes 4 and 5) with a d(AGCAGG-
CTGT-32P-C) marker labeled in an identical manner (lane 2) showed that cleavage occurs at the 3*-site of the sequence CCCTG. (C) Physical map
of the cI region of the lambda genome (19). The positions of the two topoisomerase recognition sites are shown, along with the cI markers that
we have used previously to measure recombination frequencies in transfected cells (15). A third recognition site maps to within 10 bp of the
cIc60 allele, on the lambda top strand, but has not been investigated further.
This sequence specificity was confirmed using oligonu- Although the enzyme showed a clear preference for a
5*-(C/T)CCTT-3* target sequence, additional experimentscleotide substrates designed to detect the covalent ad-
duction (2, 12, 13) and DNA strand transfer reactions (7) showed that SFV topoisomerase can recognize other se-
quences in other sequence contexts. This was demon-catalyzed by some topoisomerases. Seventy percent of
the 32P label was transferred to protein when 3 pmol of strated in experiments which substituted a DNA encod-
ing the lambda cI gene for pUC18 DNA. When we com-the (his)6-tagged enzyme was incubated with 0.6 pmol of
the double-stranded substrate d(32P-TCGCCCTTATT- pared the cleavage pattern with the known sequence of
phage lambda, we identified two principle target sitesC)rd(GAATAAGGGCGA) in reactions containing 50 mM
TrisrHCl (13). When this same 12-bp substrate (in an within cI (Fig. 3A) plus other sites on the periphery of the
gene (data not shown). One of these central sites gaveunlabeled form) was incubated with a 13 base strand
transfer acceptor molecule, up to 40% of the 3*-end label rise to a 700 base cleavage product which marked the
location of a consensus motif (5*-CCCTT-3*) at positioncould then be transferred to a 21 base recombinant mole-
cule (Fig. 2B). Thus the SFV topoisomerase will catalyze 37703 on the lambda ‘‘bottom strand.’’ However, more
cleavage was actually observed near position 37427DNA cleavage and covalent adduction reactions identical
to those catalyzed by its vaccinia and orf homologs plus where one finds a sequence matching the variant target
motif 5*-CCCTG-3* (8). This site at position 37427 was athe strand transfer reactions catalyzed by vaccinia topo-
isomerase. respectable substrate with up to 10% of the 32P label
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being transferred to protein when the topoisomerase was transfected DNA may not behave exactly as does viral
DNA, the available data suggests that topoisomeraseincubated with a facsimile of the cI target [d(32P-
activity is not a rate-limiting determinant of SFV-depen-TTGACCCTGAGC)rd(GCTCAGGGTCAA)] and then de-
dent (14) recombination frequencies. The great similaritynatured with SDS. To determine where the enzyme
between reactions catalyzed by SFV, vaccinia, and orfcleaves within this region we synthesized a larger oligo-
topoisomerases also suggests that this is probably truenucleotide duplex that could be conveniently labeled on
of poxviruses in general.the 3*-end of the scissile strand. When the cleavage
products were compared with synthetic size standards,
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